Acadian Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Buy |
1,342
+71
| +6% | +$15.5K | ﹤0.01% | 1241 |
|
|
2025
Q1 | $284K | Buy |
1,271
+157
| +14% | +$35.1K | ﹤0.01% | 1186 |
|
|
2024
Q4 | $364K | Sell |
1,114
-1,793
| -62% | -$586K | ﹤0.01% | 1149 |
|
|
2024
Q3 | $872K | Sell |
2,907
-2,019
| -41% | -$606K | ﹤0.01% | 950 |
|
|
2024
Q2 | $1.62M | Buy |
4,926
+2,565
| +109% | +$844K | 0.01% | 837 |
|
|
2024
Q1 | $933K | Sell |
2,361
-4,687
| -67% | -$1.85M | ﹤0.01% | 862 |
|
|
2023
Q4 | $2.48M | Sell |
7,048
-7,195
| -51% | -$2.53M | 0.01% | 618 |
|
|
2023
Q3 | $5.34M | Buy |
14,243
+6,736
| +90% | +$2.53M | 0.02% | 421 |
|
|
2023
Q2 | $2.87M | Buy |
7,507
+6,376
| +564% | +$2.43M | 0.01% | 606 |
|
|
2023
Q1 | $391K | Sell |
1,131
-11,152
| -91% | -$3.86M | ﹤0.01% | 1113 |
|
|
2022
Q4 | $2.89M | Sell |
12,283
-12,495
| -50% | -$2.94M | 0.01% | 584 |
|
|
2022
Q3 | $6.1M | Buy |
24,778
+6,244
| +34% | +$1.54M | 0.03% | 361 |
|
|
2022
Q2 | $5.6M | Sell |
18,534
-4,713
| -20% | -$1.42M | 0.03% | 385 |
|
|
2022
Q1 | $9.55M | Sell |
23,247
-4,381
| -16% | -$1.8M | 0.04% | 326 |
|
|
2021
Q4 | $13M | Sell |
27,628
-52,144
| -65% | -$24.5M | 0.05% | 265 |
|
|
2021
Q3 | $33.9M | Buy |
79,772
+26,306
| +49% | +$11.2M | 0.13% | 147 |
|
|
2021
Q2 | $19.2M | Buy |
53,466
+1,368
| +3% | +$491K | 0.07% | 221 |
|
|
2021
Q1 | $14.7M | Sell |
52,098
-50,935
| -49% | -$14.4M | 0.06% | 266 |
|
|
2020
Q4 | $29.2M | Sell |
103,033
-63,415
| -38% | -$18M | 0.11% | 159 |
|
|
2020
Q3 | $45.8M | Buy |
166,448
+16,497
| +11% | +$4.54M | 0.19% | 115 |
|
|
2020
Q2 | $34.1M | Buy |
149,951
+20,403
| +16% | +$4.63M | 0.15% | 157 |
|
|
2020
Q1 | $19.7M | Buy |
129,548
+115,363
| +813% | +$17.6M | 0.11% | 167 |
|
|
2019
Q4 | $2.13M | Buy |
14,185
+11,355
| +401% | +$1.71M | 0.01% | 667 |
|
|
2019
Q3 | $401K | Sell |
2,830
-597
| -17% | -$84.6K | ﹤0.01% | 1151 |
|
|
2019
Q2 | $429K | Buy |
+3,427
| New | +$429K | ﹤0.01% | 1052 |
|
|
2017
Q1 | – | Sell |
-24
| Closed | -$2K | – | 1791 |
|
|
2016
Q4 | $2K | Sell |
24
-11,706
| -100% | -$976K | ﹤0.01% | 1573 |
|
|
2016
Q3 | $875K | Buy |
11,730
+11,579
| +7,668% | +$864K | ﹤0.01% | 710 |
|
|
2016
Q2 | $12K | Buy |
151
+129
| +586% | +$10.3K | ﹤0.01% | 1202 |
|
|
2016
Q1 | $2K | Sell |
22
-24
| -52% | -$2.18K | ﹤0.01% | 1322 |
|
|
2015
Q4 | $3K | Sell |
46
-38
| -45% | -$2.48K | ﹤0.01% | 1342 |
|
|
2015
Q3 | $5K | Buy |
+84
| New | +$5K | ﹤0.01% | 1211 |
|
|
2014
Q1 | – | Sell |
-27,072
| Closed | -$1.33M | – | 1068 |
|
|
2013
Q4 | $1.33M | Buy |
27,072
+21,694
| +403% | +$1.06M | 0.01% | 530 |
|
|
2013
Q3 | $221K | Buy |
+5,378
| New | +$221K | ﹤0.01% | 738 |
|